Gevo (GEVO)

Gevo stock price today, ATLAS forecast and fair value

Basic Materials · Specialty Chemicals · NASDAQ

$1.14▼ -1.72%

Prices as of Oct 26, 2026 · USD

ATLAS fair value

ATLAS has no fair value for this stock today.

Chance of rising in 1 month

48%

that it ends higher than today in 21 sessions

0%coin flip 50%100%

This is just the summary. See everything on Gevo in ATLAS

ATLAS's own quantitative analysis, all in one place.

  • Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
  • Officers and shareholdersWho runs the company and which funds hold its shares.
  • Customer and supplier mapWho it does business with, from its own filings.
  • ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
  • AlertsWe let you know when something changes in your stocks.
See everything included
  • Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
  • NewsThe latest on the company, in one place.
  • Crisis simulatorHow your portfolio would do in a crash like 2008.
  • Practice risk-free$10,000 in virtual money to invest at real prices.
  • Global screenerSearch US stocks and stocks from 47 countries with filters.

On Gevo

  • Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
  • Officers and shareholdersWho runs the company and which funds hold its shares.
  • Customer and supplier mapWho it does business with, from its own filings.
  • Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
  • NewsThe latest on the company, in one place.

And for you

  • ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
  • AlertsWe let you know when something changes in your stocks.
  • Crisis simulatorHow your portfolio would do in a crash like 2008.
  • Practice risk-free$10,000 in virtual money to invest at real prices.
  • Global screenerSearch US stocks and stocks from 47 countries with filters.
Get started →

Plans from €3.99 a month.

ATLAS's model gives Gevo a 48% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.

In half of the simulated outcomes the price ends between $1.02 and $1.25; in 9 out of 10, between $0.85 and $1.50. Estimated annual volatility is 49%.

Price, last 12 months (weekly close)

Gevo (GEVO) — Price, last 12 months (weekly close)Oct 24, 2025: $2.47. Oct 26, 2026: $1.14. ▼$2.52$1.14Oct 24, 2025Oct 26, 2026

Key numbers

Market cap
$324M
52-week high
$2.97
52-week low
$1.09
Revenue (12 months)
$178M
Revenue growth (YoY)
+849.3%
Gross margin
46.9%
Operating margin
-11.8%
Net margin
-20.3%
Return on equity
-55.5%
Free cash flow (12 months)
$18.5M
Beta
1.05

What this means

ATLAS does not publish a fair value for GEVO right now, but it does show its odds of rising: close to a coin flip.

Over the last 52 weeks GEVO has traded between $1.09 and $2.97. Today it is 61.6% below that high and 5% above its low.

On the business: revenue grew 849.3% year over year; net margin is 20.3%.

Its beta is 1.05: it moves roughly in line with the market.

About the company

Gevo Inc. is a renewable chemicals and advanced biofuels company focused on developing and commercializing low-carbon alternatives to petroleum-based products.

Want to see everything about Gevo?

Get started →

Plans from €3.99 a month.

Comparable companies

Other companies in the same line of business:

Frequently asked questions

What does Gevo do?

Gevo Inc. is a renewable chemicals and advanced biofuels company focused on developing and commercializing low-carbon alternatives to petroleum-based products.

What is the chance GEVO goes up next month?

48%: close to a coin flip. In half of the simulated outcomes, GEVO ends the month between $1.02 and $1.25.

How big is Gevo and what is its P/E ratio?

Gevo's market capitalization is $324M. We do not show a P/E because it has no positive earnings to base one on.

How volatile is GEVO?

ATLAS estimates annual volatility at 49%. In a typical month, half of the outcomes end between $1.02 and $1.25.

Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer

ATLAS Signals

ATLAS Signals, every week

The week in the market, three stocks on ATLAS’s radar and what comes next. Get it every Monday.

By subscribing you agree to receive ATLAS Signals by email every Monday. You can unsubscribe with one click at any time. Privacy